Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
Primary Purpose
Epilepsy, Focal Epilepsy, Generalized Epilepsy
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Modified Atkins diet treatment
Sponsored by
About this trial
This is an interventional treatment trial for Epilepsy focused on measuring RCT, modified Atkins diet, epilepsy, adults, ketogenic diet
Eligibility Criteria
Inclusion Criteria:
- Focal or generalized epilepsy diagnosis
- More than 3 recordable seizures per month
- BMI > 18,5
- Not responded to at least three 3 AEDs
- 16 years or older
- Motivated to complete the diet after thorough information
- Capable of recording seizures
- Capable of preparing the diet
Exclusion Criteria:
- Hypercholesterolemia, cardiovascular disease or kidney disease
- Been on modified Atkins diet for more than one week during the last year
- Status epilepticus last six months
- epilepsy surgery or VNS implant last year
- 4 weeks continuous seizure freedom last 2 months
- PNES seizures
- other disease where dietary treatment is contraindicated
- usage of drugs or supplements that may interfere with diet or AED
- being pregnant or planning pregnancy
Sites / Locations
- Oslo University Hospital, The national Centre for epilepsy
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Modified Atkins diet treatment
No intervention
Arm Description
12 weeks of Modified Atkins diet treatment, recording seizures
12 weeks seizure record
Outcomes
Primary Outcome Measures
Change in seizure frequency
All participants record detailed seizure records for 12 weeks prior to the control/diet period. The diet group participants are subsequently treated with modified Atkins diet for 12 weeks, while the control group continue their normal diet and record seizures for another 12 weeks. Seizure records for each participant before and during intervention are compared.
Secondary Outcome Measures
Change in body weight
Change in standard 3-hrs EEG
Change in life quality measured by validated questionnaire
Change in various blood and serum measures
Change in executive functions measured with validated questionnaire
Change in seizure strength and severity measured by validated questionnaire
Full Information
NCT ID
NCT01311440
First Posted
March 7, 2011
Last Updated
September 18, 2017
Sponsor
Oslo University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01311440
Brief Title
Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
Official Title
Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy - a Controlled, Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
March 2011 (Actual)
Primary Completion Date
June 2017 (Actual)
Study Completion Date
July 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In Oslo University Hospital, department of complex epilepsy, offer ketogenic diet to treat children with medically intractable epilepsy. From 2009 we added modified Atkins diet as a treatment option for children up to 18 years.
We now initiate an open, prospective, randomized and controlled study with the aim to test the efficacy of treatment with modified Atkins diet in adults with focal and generalized epilepsy diagnoses, in order to evaluate whether this treatment should be offered to patients on a permanent basis.
Detailed Description
Poorly controlled epilepsy in adults affects health and quality of life in many ways. Within this heterogenous population there are individuals who are motivated for a very strict diet in order to reduce seizures.
Among adults with epilepsy 75 - 80 % are diagnosed with focal epilepsy, while 20 - 25 % have generalized onset of seizures.
We plan to include 92 patients with focal epilepsy diagnosis. Those are randomized into diet and control groups.
During the inclusion period we also treat patients with generalized epilepsy that qualify for participation, but these are not to be randomized, rather they will follow the diet group course. We assume 18 - 23 patients with generalized epilepsy will be included in the project.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epilepsy, Focal Epilepsy, Generalized Epilepsy
Keywords
RCT, modified Atkins diet, epilepsy, adults, ketogenic diet
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
75 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Modified Atkins diet treatment
Arm Type
Experimental
Arm Description
12 weeks of Modified Atkins diet treatment, recording seizures
Arm Title
No intervention
Arm Type
No Intervention
Arm Description
12 weeks seizure record
Intervention Type
Other
Intervention Name(s)
Modified Atkins diet treatment
Intervention Description
Eat a diet containing 16 grams of carbohydrates per day, maximize on fat. Assure sufficient intake of micronutrients.
Primary Outcome Measure Information:
Title
Change in seizure frequency
Description
All participants record detailed seizure records for 12 weeks prior to the control/diet period. The diet group participants are subsequently treated with modified Atkins diet for 12 weeks, while the control group continue their normal diet and record seizures for another 12 weeks. Seizure records for each participant before and during intervention are compared.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Change in body weight
Time Frame
12 weeks
Title
Change in standard 3-hrs EEG
Time Frame
12 weeks
Title
Change in life quality measured by validated questionnaire
Time Frame
12 weeks
Title
Change in various blood and serum measures
Time Frame
12 weeks
Title
Change in executive functions measured with validated questionnaire
Time Frame
12 weeks
Title
Change in seizure strength and severity measured by validated questionnaire
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Focal or generalized epilepsy diagnosis
More than 3 recordable seizures per month
BMI > 18,5
Not responded to at least three 3 AEDs
16 years or older
Motivated to complete the diet after thorough information
Capable of recording seizures
Capable of preparing the diet
Exclusion Criteria:
Hypercholesterolemia, cardiovascular disease or kidney disease
Been on modified Atkins diet for more than one week during the last year
Status epilepticus last six months
epilepsy surgery or VNS implant last year
4 weeks continuous seizure freedom last 2 months
PNES seizures
other disease where dietary treatment is contraindicated
usage of drugs or supplements that may interfere with diet or AED
being pregnant or planning pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karl Otto Nakken
Organizational Affiliation
Oslo University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oslo University Hospital, The national Centre for epilepsy
City
Sandvika
State/Province
Bærum Postterminal
ZIP/Postal Code
1306
Country
Norway
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
We'll reach out to this number within 24 hrs